Search Site
  • 0
    My Cart

    Click Here to Find How Many Items You Have Added:)

    image loader

    Adding item(s) to cart......

Home >> Signaling Pathways >> DNA Damage/DNA Repair

DNA Damage/DNA Repair

Products for  DNA Damage/DNA Repair

  1. Cat.No. Product Name Information
  2. GC19941 DL-Leucic Acid DL-Leucic Acid Chemical Structure
  3. GC38000 β-Boswellic acid A pentacyclic triterpene with diverse bioactivities β-Boswellic acid Chemical Structure
  4. GC31365 γ-Oryzanol γ-Oryzanol is a potent DNA methyltransferases (DNMTs) inhibitor in the striatum of mice. γ-Oryzanol Chemical Structure
  5. GC38194 (±)-10-Hydroxycamptothecin (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity. (±)-10-Hydroxycamptothecin Chemical Structure
  6. GC73670 (αR)-Cyclopropaneacetamide-Exatecan (αR)-Cyclopropaneacetamide-Exatecan (compound 2-A), an Exenotecan derivative, is a cytotoxic agent. (αR)-Cyclopropaneacetamide-Exatecan Chemical Structure
  7. GC33107 (±)-BAY-1251152

    (±)-BAY-1251152; (±)-VIP152

     (±)-BAY-1251152 ((±)-BAY-1251152) is a racemic mixture of BAY-1251152. BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor. (±)-BAY-1251152 Chemical Structure
  8. GC10867 (+)-Aphidicolin

    ICI 69653, NSC 234714

     Aphidicolin ((+)-Aphidicolin), a reversible inhibitor of eukaryotic nuclear DNA replication, can block the cell cycle at the pre-S phase. (+)-Aphidicolin Chemical Structure
  9. GC34955 (+)-CBI-CDPI1 (+)-CBI-CDPI1 is an enhanced functional analog of CC-1065. (+)-CBI-CDPI1 is a DNA alkylating agent. (+)-CBI-CDPI1 is an antibody drug conjugates (ADCs) toxin. (+)-CBI-CDPI1 Chemical Structure
  10. GC34956 (+)-CBI-CDPI2 (+)-CBI-CDPI2 is an enhanced functional analog of CC-1065. (+)-CBI-CDPI1 is a DNA alkylating agent. (+)-CBI-CDPI2 is an antibody drug conjugates (ADCs) toxin. (+)-CBI-CDPI2 Chemical Structure
  11. GC32429 (-)-BAY-1251152

    (-)-BAY-1251152; (-)-VIP152

     (-)-BAY-1251152 ((-)-BAY-1251152) is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor. (-)-BAY-1251152 Chemical Structure
  12. GC48635 (-)-Cryptopleurine

    (R)-Cryptopleurine, NSC 19912

     An alkaloid with diverse biological activities (-)-Cryptopleurine Chemical Structure
  13. GC40076 (-)-Voacangarine

    NSC 306219, (-)-Voacristine

     (-)-Voacangarine is an indole alkaloid originally isolated from V. (-)-Voacangarine Chemical Structure
  14. GC73057 (1R,9R)-Exatecan mesylate

    (1R,9R)-DX8951f

     (1R,9R)-Exatecan mesylate((1R,9R)-DX8951f) is an isomer of Exatecan mesylate. (1R,9R)-Exatecan mesylate Chemical Structure
  15. GC73056 (1S,9R)-Exatecan mesylate

    (1S,9R)-DX8951f

     (1S,9R)-Exatecan mesylate ((1S,9R)-DX8951f) is an isomer of Exatecan mesylate. (1S,9R)-Exatecan mesylate Chemical Structure
  16. GC38377 (2S,3R)-Voruciclib hydrochloride (2S,3R)-Voruciclib hydrochloride is the enantiomer of Voruciclib hydrochloride. (2S,3R)-Voruciclib is an orally active CDK inhibitor. (2S,3R)-Voruciclib hydrochloride Chemical Structure
  17. GC41695 (6R,S)-5,6,7,8-Tetrahydrofolic Acid (hydrochloride)

    Tetrahydrofolate, THFA

     (6R,S)-5,6,7,8-Tetrahydrofolic acid (THFA), the reduced form of folic acid, serves as a cofactor in methyltransferase reactions and is the major one-carbon carrier in one carbon metabolism. (6R,S)-5,6,7,8-Tetrahydrofolic Acid (hydrochloride) Chemical Structure
  18. GC41088 (6S)-Tetrahydrofolic Acid

    (6S)-Tetrahydrofolic acid is a diastereomer of tetrahydrofolic acid, a reduced form of folic acid that serves as a cofactor in methyltransferase reactions and is the major one-carbon carrier in one carbon metabolism.

     (6S)-Tetrahydrofolic Acid Chemical Structure
  19. GC72591 (E,E)-RGFP966 (E,E)-RGFP966 is a selective and CNS permeable HDAC3 inhibitor that can be used for the research of Huntington’s disease. (E,E)-RGFP966 Chemical Structure
  20. GC62735 (E/Z)-GO289 (E/Z)-GO289 is a potent and selective casein kinase 2 (CK2) inhibitor (IC50=7 nM). (E/Z)-GO289 strongly lengthens circadian period. (E/Z)-GO289 exhibits cell type–dependent inhibition of cancer cell growth that correlated with cellular clock function. (E/Z)-GO289 Chemical Structure
  21. GC64429 (E/Z)-Zotiraciclib citrate

    (E/Z)-TG02 citrate; (E/Z)-SB1317 citrate

     (E/Z)-Zotiraciclib citrate is a potent CDK2, JAK2, and FLT3 inhibitor. (E/Z)-Zotiraciclib citrate Chemical Structure
  22. GC63864 (E/Z)-Zotiraciclib hydrochloride

    (E/Z)-TG02 hydrochloride; (E/Z)-SB1317 hydrochloride

     (E/Z)-Zotiraciclib ((E/Z)-TG02) hydrochloride is a potent CDK2, JAK2, and FLT3 inhibitor. (E/Z)-Zotiraciclib hydrochloride Chemical Structure
  23. GC74261 (R)-(+)-O-Demethylbuchenavianine (R)-(+)-O-Demetlbuchenavianine is an inhibitor for Cyclin-dependent kinases (CDK). (R)-(+)-O-Demethylbuchenavianine Chemical Structure
  24. GC69793 (R)-5-O-Benzoyl-1,2-di-O-isopropylidene-alpha-D-xylofuranose

    (R)-5-O-Benzoyl-1,2-di-O-isopropylidene-alpha-D-xylofuranose is a purine nucleoside analogue. Purine nucleoside analogues have broad anti-tumor activity and target inert lymphoid malignancies. The anticancer mechanism in this process depends on inhibiting DNA synthesis, inducing apoptosis (cell death), etc.

     (R)-5-O-Benzoyl-1,2-di-O-isopropylidene-alpha-D-xylofuranose Chemical Structure
  25. GC41716 (R)-CR8 Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising targets for cancer therapy. (R)-CR8 Chemical Structure
  26. GC39281 (R)-CR8 trihydrochloride

    CR8, (R)-Isomer trihydrochloride

     (R)-CR8 (CR8) trihydrochloride, a second-generation analog of Roscovitine, is a potent CDK1/2/5/7/9 inhibitor. (R)-CR8 trihydrochloride Chemical Structure
  27. GC74127 (R)-Exatecan Intermediate 1 (R)-Exatecan Intermediate 1 is an isomer of Exatecan Intermediate 1. (R)-Exatecan Intermediate 1 Chemical Structure
  28. GC64210 (R)-GSK-3685032 (R)-GSK-3685032 is the R-enantiomer of GSK-3685032. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition. (R)-GSK-3685032 Chemical Structure
  29. GC41633 (R)-Prunasin (R)-Prunasin is a inhibitor of DNA Polymerase β. (R)-Prunasin Chemical Structure
  30. GC34124 (rel)-MC180295

    (rel)-MC180295

     (rel)-MC180295 ((rel)-(rel)-MC180295) is a potent and selective CDK9-Cyclin T1 inhibitor, with an IC50 of 5 nM, at least 22-fold more selective for CDK9 over other CDKs. (rel)-MC180295 also inhibits GSK-3α and GSK-3β. (rel)-MC180295 ((rel)-(rel)-MC180295) has potent anti-tumor effect. (rel)-MC180295 Chemical Structure
  31. GC74262 (S)-(-)-O-Demethylbuchenavianine (S)-(-)-O-Demetlbuchenavianine (Compound (S)-(−)-1) is a flavonoidal alkaloids. (S)-(-)-O-Demethylbuchenavianine Chemical Structure
  32. GC10098 (S)-10-Hydroxycamptothecin

    ChEMBL 273862, NSC 107124

     inhibitor of topoisomerase I (S)-10-Hydroxycamptothecin Chemical Structure
  33. GC34999 (S)-Ceralasertib

    (S)-AZD6738

     (S)-Ceralasertib ((S)-AZD6738) is extracted from patent WO2011154737A1, Compound II, exhibits an IC50 of 2.578 nM.(S)-Ceralasertib is a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical and pharmacokinetic (PK) characteristics.(S)-Ceralasertib is developed improving aqueous solubility and eliminates CYP3A4 time-dependent inhibition. (S)-Ceralasertib Chemical Structure
  34. GC46351 (S)-CR8 An inhibitor of cyclin-dependent kinases (S)-CR8 Chemical Structure
  35. GC13136 (S)-Crizotinib Potent MTH1 inhibitor (S)-Crizotinib Chemical Structure
  36. GC65877 (S)-GFB-12811 (S)-GFB-12811 (compound 596) is a potent and selective CDK5 inhibitor, with an IC50 value less than 10 nM. (S)-GFB-12811 can be used in the research of cell cycle progression, neuronal development, tumorigenesis. (S)-GFB-12811 Chemical Structure
  37. GC65997 (S)-LY3177833 hydrate (S)-LY3177833 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor. (S)-LY3177833 hydrate shows broad in vitro anticancer activity. (S)-LY3177833 hydrate Chemical Structure
  38. GC60421 (S)-Seco-Duocarmycin SA (S)-Seco-Duocarmycin SA is a DNA alkylator, cytotoxic to cancer cells, and acts as a ADC cytotoxin for antibody-drug conjugates. (S)-Seco-Duocarmycin SA Chemical Structure
  39. GC73435 (S)-TNG260 (S)-TNG260 is an isomer of TNG260. (S)-TNG260 Chemical Structure
  40. GC39842 (Z)-4EGI-1 (Z)-4EGI-1 is the Z-isomer of 4EGI-1 and is an inhibitor of eIF4E/eIF4G interaction and of translation initiation. (Z)-4EGI-1 effectively binds to eIF4E with an IC50 of 43.5 μM and a Kd value of 8.74 μM. (Z)-4EGI-1 has anticancer activity. (Z)-4EGI-1 Chemical Structure
  41. GC68484 1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose

    1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose is a purine nucleoside analogue. Purine nucleoside analogues have broad anti-tumor activity and target malignant tumors in the inert lymphatic system. The anticancer mechanism in this process depends on inhibiting DNA synthesis, inducing apoptosis (cell death), etc.

     1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose Chemical Structure
  42. GC19528 1,4-Benzoquinone

    p-Benzoquinone, NSC 36324, p-Quinone

     A toxic metabolite of benzene 1,4-Benzoquinone Chemical Structure
  43. GC41859 1,5,7-Triazabicyclo[4.4.0]dec-5-ene

    TBD, Triazabicyclodecene

     1,5,7-Triazabicyclo[4.4.0]dec-5-ene is a bicyclic guanidine base that can be used as a catalyst for a variety of base-mediated organic transformations, including Michael additions, Wittig reactions, Henry reactions, and transesterification reactions. 1,5,7-Triazabicyclo[4.4.0]dec-5-ene Chemical Structure
  44. GC65551 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine is a bicyclic nucleoside. 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine Chemical Structure
  45. GC71294 1-(2-Deoxy-β-D-threo-pentofuranosyl)thymine 1-(2-Deoxy-β-D-threo-pentofuranosyl)thymine is a thymidine analog. 1-(2-Deoxy-β-D-threo-pentofuranosyl)thymine Chemical Structure
  46. GC49470 1-Ethyl-1-nitrosourea (hydrate)

    ENU, Ethylnitrosourea, N-Ethyl-N-nitrosourea, N-Nitroso-N-ethylurea

     A DNA alkylating agent 1-Ethyl-1-nitrosourea (hydrate) Chemical Structure
  47. GC48909 1-Hydroxyanthraquinone

    NSC 8640

     An anthraquinone with genotoxic and carcinogenic activities 1-Hydroxyanthraquinone Chemical Structure
  48. GC65038 1-Methylinosine

    1-methyl Inosine, N1-Methylinosine

     1-Methylinosine is a modified nucleotide found at position 37 in tRNA 3' to the anticodon of eukaryotic tRNA. 1-Methylinosine Chemical Structure
  49. GC49872 10-Formyltetrahydrofolate (sodium salt) (technical grade)

    10-CHO-FH4, 10-CHO-THF, N10-Formyltetrahydrofolate, 10-formyl H4PteGlu, 10-fTHF

     10-Formyltetrahydrofolate (sodium salt) (technical grade) is a form of tetrahydrofolic acid that acts as a donor of formyl groups in anabolism. 10-Formyltetrahydrofolate (sodium salt) (technical grade) Chemical Structure
  50. GC63796 116-9e

    MAL2-11B

     116-9e (MAL2-11B) is a Hsp70 co-chaperone DNAJA1 inhibitor. 116-9e Chemical Structure
  51. GC71326 12R-LOX-IN-2 12R-LOX-IN-2 (compound 7b) is an inhibitor of 12R-lipoxygenase (12R-LOX). 12R-LOX-IN-2 Chemical Structure
  52. GC49759 13C17-Mycophenolic Acid

    13C17-MPA

     An internal standard for the quantification of mycophenolic acid 13C17-Mycophenolic Acid Chemical Structure
  53. GC46474 18-Deoxyherboxidiene

    RQN-18690A

     A bacterial metabolite with antiangiogenic activity 18-Deoxyherboxidiene Chemical Structure
  54. GC90803 2',3'-Dideoxyadenosine-5'-O-triphosphate (sodium salt)

    A reverse transcriptase inhibitor and an active metabolite of ddA and ddI

     2',3'-Dideoxyadenosine-5'-O-triphosphate (sodium salt) Chemical Structure
  55. GC73523 2'-Deoxy-N3-methylcytidine hydriodide 2’-Deoxy-N3-metlcytidine driodide is a purine nucleoside analog. 2'-Deoxy-N3-methylcytidine hydriodide Chemical Structure
  56. GC65489 2'-F-Bz-dC Phosphoramidite 2'-F-Bz-dC Phosphoramidite can be used in the synthesis of oligoribonucleotides. 2'-F-Bz-dC Phosphoramidite Chemical Structure
  57. GC66651 2'-O,4'-C-Methyleneadenosine

    LNA-A

     2'-O,4'-C-Methyleneadenosine (LNA-A) is a locked nucleic acid (LNA) and is also an adenosine analog. 2'-O,4'-C-Methyleneadenosine Chemical Structure
  58. GC66654 2'-O,4'-C-Methylenecytidine

    LNA-C(Bz)

     2'-O,4'-C-Methylenecytidine (LNA-C(Bz)) is a bicyclic nucleoside analogue with fixed N-type conformation. 2'-O,4'-C-Methylenecytidine can be used to synthesize oligonucleotides. 2'-O,4'-C-Methylenecytidine forms duplexes with complementary DNA and RNA strands. 2'-O,4'-C-Methylenecytidine Chemical Structure
  59. GC66655 2'-O,4'-C-Methyleneguanosine

    LNA-G

     2′-O,4′-C-Methyleneguanosine (LNA-G) is a reverse guanine analogue, where LNA (locked nucleic acid) is a nucleic acid analogue. LNA modification can be used in a variety of applications such as effective binding affinity to complementary sequences and greater nuclease resistance than natural nucleotides, offering great potential for applications in disease diagnosis and research. LNA-G is also available via KOD DNA polymerase, which allows the integration of LNA-G nucleotides into the DNA strand. 2'-O,4'-C-Methyleneguanosine Chemical Structure
  60. GC52183 2'-O-Methyl-5-methyluridine

    2'-O-Methylribothymidine, 2'-O-Methylthymidine

     2'-O-Methyl-5-methyluridine Chemical Structure
  61. GC66713 2'-O-MOE-5-Me-C(Bz) 2'-O-MOE-5-Me-C (Bz) is a nucleotide for the stereoselective synthesis of nucleoside alkyl phosphonates. 2'-O-MOE-5-Me-C(Bz) Chemical Structure
  62. GC66657 2'-O-MOE-5-Me-rC 2'-O-MOE-5-Me-rC is an active compound. 2'-O-MOE-5-Me-rC can be used for oligonucleotide synthesis. 2'-O-MOE-5-Me-rC Chemical Structure
  63. GC66091 2'-O-MOE-5-Me-rU 2'-O-MOE-5-Me-rU is an active compound. 2'-O-MOE-5-Me-rU can be used for oligonucleotide synthesis. 2'-O-MOE-5-Me-rU Chemical Structure
  64. GC66656 2'-O-MOE-rC 2'-O-MOE-rC is a 2'-O-MOE modified nucleoside. 2'-O-MOE-rC can be used for synthesis of DNA. 2'-O-MOE-rC Chemical Structure
  65. GC66652 2'-O-MOE-U 2'-O-MOE-U is a phosphoramidite, can be used for oligonucleotide synthesis. 2'-O-MOE-U Chemical Structure
  66. GC65170 2′,3′-Di-O-acetylguanosine 2′,3′-Di-O-acetylguanosine is a nucleoside analog. 2′,3′-Di-O-acetylguanosine Chemical Structure
  67. GC67384 2′-Deoxy-β-L-uridine 2'-Deoxy-β-L-uridine is a nucledside analogue and a specific substrate for the viral enzyme, shows no stereospecificity against herpes simplex 1 (HSV1) thymidine kinase (TK). 2′-Deoxy-β-L-uridine exerts antiviral activity via the interation of 5'-triphosphates with the viral DNA polymerase. 2′-Deoxy-β-L-uridine Chemical Structure
  68. GC61667 2′-Deoxy-2′-fluoroadenosine 2′-Deoxy-2′-fluoroadenosine can be used for thesynthesisof 2′-Deoxy-2′-fluoro-modified oligonucleotides hybridized with RNA. 2′-Deoxy-2′-fluoroadenosine can be cleaved efficiently by E. coli purine nucleoside phosphorylase (PNP) to the toxic agent 2-fluoroadenine (FAde). 2′-Deoxy-2′-fluoroadenosine shows excellent in vivo activity against tumors expressing E. coli PNP. 2′-Deoxy-2′-fluoroadenosine Chemical Structure
  69. GC62530 2’-O-Me-C(Bz) Phosphoramidite 2’-O-Me-C(Bz) Phosphoramidite is a modified phosphoramidite monomer, which can be used for the oligonucleotide synthesis. 2’-O-Me-C(Bz) Phosphoramidite Chemical Structure
  70. GC62529 2’-OMe-A(Bz) Phosphoramidite 2’-OMe-A(Bz) Phosphoramidite is a modified phosphoramidite monomer, which can be used for the oligonucleotide synthesis. 2’-OMe-A(Bz) Phosphoramidite Chemical Structure
  71. GC62531 2’-OMe-G(ibu) Phosphoramidite 2’-OMe-G(ibu) Phosphoramidite is a modified phosphoramidite monomer, which can be used for the oligonucleotide synthesis. 2’-OMe-G(ibu) Phosphoramidite Chemical Structure
  72. GC46508 2',2'-Difluoro-2'-deoxyuridine

    dFdU

     An active metabolite of gemcitabine 2',2'-Difluoro-2'-deoxyuridine Chemical Structure
  73. GC45321 2',3',5'-Triacetyluridine   2',3',5'-Triacetyluridine Chemical Structure
  74. GC42061 2',3'-Dideoxyadenosine 5'-triphosphate

    2',3'-Dideoxyadenosine 5'-triphosphate

     2',3'-Dideoxyadenosine 5'-triphosphate (2',3'-Dideoxyadenosine 5'-triphosphate), an active metabolite of 2',3'-dideoxyinosine, is a chain-elongating inhibitor of DNA polymerase. 2',3'-Dideoxyadenosine 5'-triphosphate Chemical Structure
  75. GC46519 2',3'-O-Isopropylideneguanosine A building block 2',3'-O-Isopropylideneguanosine Chemical Structure
  76. GC46540 2'-Deoxyadenosine-5'-triphosphate (sodium salt hydrate) A purine nucleotide 2'-Deoxyadenosine-5'-triphosphate (sodium salt hydrate) Chemical Structure
  77. GC48440 2'-Deoxycytidine-5'-triphosphate (sodium salt)

    dCTP

     2'-Deoxycytidine-5'-triphosphate (sodium salt) (dCTP trisodium salt) is a nucleoside triphosphate that can be used for DNA synthesis. 2'-Deoxycytidine-5'-triphosphate (sodium salt) Chemical Structure
  78. GC42151 2'-Deoxyguanosine 5'-monophosphate (sodium salt hydrate)

    dGMP

     2'-Deoxyguanosine 5'-monophosphate (dGMP) is used as a substrate of guanylate kinases to generate dGDP, which in turn is phosphorylated to dGTP, a nucleotide precursor used in DNA synthesis. 2'-Deoxyguanosine 5'-monophosphate (sodium salt hydrate) Chemical Structure
  79. GC33430 2'-Deoxypseudoisocytidine 2'-Deoxypseudoisocytidine is a nucleoside analogue. 2'-Deoxypseudoisocytidine Chemical Structure
  80. GC35072 2'-O,4'-C-Methyleneuridine 2'-O,4'-C-Methyleneuridine (Compound 15a) is a bicyclic nucleoside. 2'-O,4'-C-Methyleneuridine Chemical Structure
  81. GC42080 2'2'-cGAMP (sodium salt)

    Adenosine-Guanosine 2’,2’-cyclic monophosphate, cGAMP(2’-5’), 2’,2’-Cyclic GMP-AMP

     2'2'-cGAMP is a synthetic dinucleotide (CDN) that contains non-canonical 2'5'-phosphodiester bonds. 2'2'-cGAMP (sodium salt) Chemical Structure
  82. GC64399 2,4,6-Trihydroxybenzoic acid 2,4,6-Trihydroxybenzoic acid, the flavonoid metabolite, is a CDK inhibitor. 2,4,6-Trihydroxybenzoic acid can be used for the research of cancer. 2,4,6-Trihydroxybenzoic acid Chemical Structure
  83. GC60459 2,4-D (2,4-Dichlorophenoxyacetic acid)

    2,4D, Diclordon, Vidon 638

     2,4-D (2,4-Dichlorophenoxyacetic acid) (2,4-D (2,4-Dichlorophenoxyacetic acid) ichlorophenoxyacetic acid) is a selective systemic herbicide for the control of broad-leaved weeds. 2,4-D (2,4-Dichlorophenoxyacetic acid) Chemical Structure
  84. GC71530 2,4-D-13C6 2,4-D-13C6 is the 13C-labeled 2,4-D. 2,4-D-13C6 Chemical Structure
  85. GC46524 2,6-Dichloropurine-9-β-D-riboside

    2,6-Dichloropurine riboside

    A building block

     2,6-Dichloropurine-9-β-D-riboside Chemical Structure
  86. GC33496 2-(Methylamino)-1H-purin-6(7H)-one (N2-methylguanine) 2-(Methylamino)-1H-purin-6(7H)-one (N2-methylguanine) (N2-Methylguanine) is a modified nucleoside. 2-(Methylamino)-1H-purin-6(7H)-one (N2-methylguanine) Chemical Structure
  87. GC64983 2-Amino-2'-deoxyadenosine 2-Amino-2'-deoxyadenosine is a deoxyribonucleoside used for the oligonucleotide synthesis. 2-Amino-2'-deoxyadenosine Chemical Structure
  88. GC71560 2-Iodoacetamide-d4 2-Iodoacetamide-d4 is the deuterium labeled 2-Iodoacetamide. 2-Iodoacetamide-d4 Chemical Structure
  89. GC71208 2-Methyladenosine 2-Methyladenosine is an adenosine analogue. 2-Methyladenosine Chemical Structure
  90. GC73004 2-Methylthioadenosine 2-Metlthioadenosine is a purine nucleoside analog. 2-Methylthioadenosine Chemical Structure
  91. GC39527 2-O-Methylcytosine 2-O-Methylcytosine, an O-alkylated analogue a DNA adduct, is the damaged nucleobase. 2-O-Methylcytosine Chemical Structure
  92. GC49348 2-Thiocytidine

    α-2-Thioribocytidine

     A modified nucleobase 2-Thiocytidine Chemical Structure
  93. GC42197 2-Thiouridine

    1-β-D-ribofuranosyl-2-thiouracil, s2U

     2-Thiouridine (s2U) is a modified nucleobase found in tRNAs that is known to stabilize U:A pairs and modestly destabilize U:G wobble pairs. 2-Thiouridine Chemical Structure
  94. GC65083 3'-Azido-3'-deoxy-5-fluorocytidine 3'-Azido-3'-deoxy-5-fluorocytidine (Compound 12) is a cytidine derivative. 3'-Azido-3'-deoxy-5-fluorocytidine Chemical Structure
  95. GC73400 3'-Azido-3'-deoxyuridine 3’-Azido-3’-deoxyuridine is a purine nucleoside analogue. 3'-Azido-3'-deoxyuridine Chemical Structure
  96. GC71204 3'-O-(2-Methoxyethyl)guanosine 3’-O-(2-Methoxyethyl)guanosine is a guanosine analogue. 3'-O-(2-Methoxyethyl)guanosine Chemical Structure
  97. GC64985 3'-O-Methylguanosine 3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-Methylguanosine Chemical Structure
  98. GC90976 3'-O-Methylguanosine-5'-O-triphosphate (sodium salt)

    A methylated derivative of GTP

     3'-O-Methylguanosine-5'-O-triphosphate (sodium salt) Chemical Structure
  99. GC68542 3'Ome-m7GpppAmpG ammonium

    m7GpppAmpG

    3'Ome-m7GpppAmpG ammonium is a trinucleotide cap analog containing locked nucleic acid (LNA) molecules. It has significant translation efficiency and can be used as a potential molecular biology tool in the fields of mRNA vaccines and mRNA transfection, such as protein production, gene therapy, and anti-cancer immunity.

     3'Ome-m7GpppAmpG ammonium Chemical Structure
  100. GC40618 3',4',7-Trihydroxyisoflavone

    3'-hydroxy Daidzein, 3’,4’,7-THIF

     3',4',7-Trihydroxyisoflavone, a major metabolite of Daidzein, is an ATP-competitive inhibitor of Cot (Tpl2/MAP3K8) and MKK4. 3',4',7-Trihydroxyisoflavone has anticancer, anti-angiogenic, chemoprotective, and free radical scavenging activities. 3',4',7-Trihydroxyisoflavone Chemical Structure
  101. GC35105 3'-Azido-3'-deoxy-beta-L-uridine 3'-Azido-3'-deoxy-beta-L-uridine (Compound 25) is a nucleoside derivative. 3'-Azido-3'-deoxy-beta-L-uridine Chemical Structure

Items 1 to 100 of 1684 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction